Related Experiment Video
Updated: May 16, 2026

Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
[Treatment of high grade intracranial stenoses]
1Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Kirrberger Straße, Homburg/Saar, Deutschland.
Insights
Intracranial stenosis causes 10% of strokes. This study retrospectively analyzed endovascular treatment for high-grade intracranial stenosis, comparing it with aggressive medical management.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Medicine
Context:
- Intracranial stenosis is a significant cause of stroke, accounting for approximately 10% of all cases.
- Current treatment options include medical management, intracranial bypass surgery, and endovascular procedures like angioplasty and stenting.
- Despite advances, patients with high-grade intracranial stenosis often face a poor prognosis, highlighting the need for effective therapies.
Purpose:
- To retrospectively evaluate the effectiveness and feasibility of endovascular treatment (angioplasty and stenting) for symptomatic high-grade intracranial stenosis.
- To compare the outcomes of endovascular therapy with aggressive medical treatment, as suggested by the SAMMPRIS trial.
- To analyze patient data from the department of neuroradiology at Homburg University of Saarland.
Summary:
- The study focuses on patients with symptomatic high-grade intracranial stenosis, a condition linked to a substantial stroke risk.
- It examines intracranial angioplasty and stenting as endovascular treatment options, building upon previous research like the WASID trial.
- Findings are contextualized within the broader debate on aggressive medical management versus endovascular intervention, particularly following the SAMMPRIS trial.
Impact:
- Provides insights into the comparative effectiveness of endovascular treatment versus medical management for intracranial stenosis.
- Contributes to the evidence base for managing patients with high-grade intracranial stenosis and reducing secondary stroke risk.
- Informs clinical decision-making regarding treatment strategies for this challenging patient population.
Abstract:
Intracranial stenosis is the cause of 10 % of strokes. Besides medicinal treatment, intracranial bypass surgery, percutaneous transluminal angioplasty and stenting are available treatment approaches. According to the 2005 published WASID trial antiplatelets should be preferred to oral anticoagulation in secondary preventive therapy of ischemic stroke; however patients with high grade intracranial stenosis still have a poor prognosis. Intracranial bypass surgery, which was taken into account as a treatment option even in 1985, showed a generally worse outcome in relation to medicinal therapy. Intracranial angioplasty and stenting, representing improvements in endovascular treatment, were proven to be effective and feasible treatment approaches for patients with symptomatic high grade intracranial stenosis. Within the scope of the SAMMPRIS trial published in 2011, which propagated an advantage of aggressive medicinal treatment versus endovascular therapy, a retrospective study was performed at the department of neuroradiology of the Homburg University of Saarland.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Aneurysm III: Interprofessional Care
Mitral Stenosis III: Medical Management
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
